Histologic and Clinical Changes in Vulvovaginal Tissue After Treatment With a Transcutaneous Temperature-Controlled...

Area of Science:

• Gynecology
• Dermatology
• Regenerative Medicine

Background:

• Vulvovaginal laxity (VVL), atrophic vaginitis (AV), orgasmic dysfunction (OD), and stress urinary incontinence (SUI) are common concerns.
• Transcutaneous temperature-controlled radiofrequency (TTCRF) shows promise for treating these conditions.
• Histopathologic evidence validating TTCRF's efficacy is lacking.

Purpose of the Study:

• To evaluate the clinical and histological effects of TTCRF on vulvovaginal tissues.
• To assess changes in VVL, AV, OD, and SUI following TTCRF treatment.
• To provide histopathologic evidence for TTCRF's mechanism of action.

Main Methods:

• Prospective, nonrandomized trial involving 10 female subjects.
• Three TTCRF sessions were administered at 4-week intervals.
• Histological analysis of biopsies from 5 subjects before and after treatment.

Main Results:

• Significant improvement in VVL from baseline to Day 120 (p = .001).
• Significant improvement in sexual satisfaction by Day 60 (p = .001) and AV by Day 120 (p = .048).
• Histology revealed increased collagen, elastin, vascularity, and small nerve fibers post-treatment.

Conclusions:

• TTCRF significantly improves AV, VVL, and sexual satisfaction.
• Milder improvements were observed in OD and SUI.
• Histological findings demonstrate neocollagenesis, neoelastogenesis, neoangiogenesis, and neurogenesis.